Effects of a Pasty Bone Cement Containing Brain-Derived Neurotrophic Factor-Functionalized Mesoporous Bioactive Glass Particles on Metaphyseal Healing in a New Murine Osteoporotic Fracture Model
Authors:
- Vivien KauschkeVKVivien Kauschke
- Maike SchneiderMSMaike Schneider
- Annika JauchAJAnnika Jauch
- Matthias SchumacherMSMatthias Schumacher
- Marian KampschulteMKMarian Kampschulte
- Marcus RohnkeMRMarcus Rohnke
- Anja HenssAHAnja Henss
- Coralie BambergCBCoralie Bamberg
- Katja TrinkausKTKatja Trinkaus
- Michael GelinskyMichael Gelinsky
- Katrin Susanne LipsKatrin Susanne Lips
Open Access
- 9 November 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (11) , 3531
Abstract
The development of new and better implant materials adapted to osteoporotic bone is still urgently required. Therefore, osteoporotic muscarinic acetylcholine receptor M3 (M3 mAChR) knockout (KO) and corresponding wild type (WT) mice underwent osteotomy in the distal femoral metaphysis. Fracture gaps were filled with a pasty α-tricalcium phosphate (α-TCP)-based hydroxyapatite (HA)-forming bone cement containing mesoporous bioactive CaP-SiO2 glass particles (cement/MBG composite) with or without Brain-Derived Neurotrophic Factor (BDNF) and healing was analyzed after 35 days. Histologically, bone formation was significantly increased in WT mice that received the BDNF-functionalized cement/MBG composite compared to control WT mice without BDNF. Cement/MBG composite without BDNF increased bone formation in M3 mAChR KO mice compared to equally treated WT mice. Mass spectrometric imaging showed that the BDNF-functionalized cement/MBG composite implanted in M3 mAChR KO mice was infiltrated by newly formed tissue. Leukocyte numbers were significantly lower in M3 mAChR KO mice treated with BDNF-functionalized cement/MBG composite compared to controls without BDNF. C-reactive protein (CRP) concentrations were significantly lower in M3 mAChR KO mice that received the cement/MBG composite without BDNF when compared to WT mice treated the same. Whereas alkaline phosphatase (ALP) concentrations in callus were significantly increased in M3 mAChR KO mice, ALP activity was significantly higher in WT mice. Due to a stronger effect of BDNF in non osteoporotic mice, higher BDNF concentrations might be needed for osteoporotic fracture healing. Nevertheless, the BDNF-functionalized cement/MBG composite promoted fracture healing in non osteoporotic bone.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB/TRR 79, projects B7, M2, M5 and Z3)
This publication has 47 references indexed in Scilit:
- Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A reviewActa Biomaterialia, 2012
- M3 Subtype of Muscarinic Acetylcholine Receptor Promotes Cardioprotection via the Suppression of miR-376b-5pPLOS ONE, 2012
- Induction of osteoporosis with its influence on osteoporotic determinants and their interrelationships in rats by DEXAMedical Science Monitor, 2012
- Estimation of C-reactive Protein Associated with Mandibular FractureJournal of Maxillofacial and Oral Surgery, 2011
- Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1Journal of Bone and Mineral Research, 2011
- Signaling through the M3 Muscarinic Receptor Favors Bone Mass Accrual by Decreasing Sympathetic ActivityCell Metabolism, 2010
- Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineeringMicroporous and Mesoporous Materials, 2008
- Choline Produces Cytoprotective Effects Against Ischemic Myocardial Injuries: Evidence for the Role of Cardiac M3 Subtype Muscarinic Acetylcholine ReceptorsCellular Physiology and Biochemistry, 2005
- Biomechanical evaluation of healing in a non‐critical defect in a large animal model of osteoporosisJournal of Orthopaedic Research, 2003
- Differential Staining of Calcified Tissues in Plastic Embedded Microtome Sections by A Modification of Movat's Pentachrome StainStain Technology, 1977